Death; Neonatal
8
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
38%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
NICU Antibiotics and Outcomes Trial
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Kangaroo Mother Care Before Stabilisation Amongst Low Birth Weight Neonates in Africa
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
Trial to Compare BCG-Bulgaria and BCG-Denmark
Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2
Safeguarding the Brain of Our Smallest Infants Phase III